Citi Maintains Buy on LifePoint Hospitals

Citi is out with its report today on LifePoint Hospitals LPNT, maintaining Buy. In its report, Citi writes, "We rate Lifepoint Hospitals Buy/Low Risk (1L). We expect consistent outpatient growth to drive SS revenues and profitability above market expectations. We believe consistent results will improve LPNT's current sector-low EBITDA valuation." Citi maintains a $37 PT on LPNT. Shares of LPNT closed Monday at $35.68.